LON:INDV - Indivior Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 48.56 -4.50 (-8.48 %)
(As of 05/19/2019 02:19 AM ET)
Previous CloseGBX 48.56
Today's RangeGBX 45.66 - GBX 53.20
52-Week RangeGBX 20.98 - GBX 504.60
Volume8.54 million shs
Average Volume2.44 million shs
Market Capitalization£354.50 million
P/E Ratio1.43
Dividend YieldN/A
BetaN/A
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence. The company's product pipeline focuses on treating opioid use disorder, alcohol use disorder, opiate overdose, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Receive INDV News and Ratings via Email

Sign-up to receive the latest news and ratings for INDV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drugs - Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1753-217800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£988 million
Cash FlowGBX 144.39 per share
Book ValueGBX 18.20 per share

Profitability

Miscellaneous

Employees915
Market Cap£354.50 million
Next Earnings Date7/23/2019 (Estimated)
OptionableNot Optionable

Indivior (LON:INDV) Frequently Asked Questions

What is Indivior's stock symbol?

Indivior trades on the London Stock Exchange (LON) under the ticker symbol "INDV."

When is Indivior's next earnings date?

Indivior is scheduled to release their next quarterly earnings announcement on Tuesday, July 23rd 2019. View Earnings Estimates for Indivior.

What price target have analysts set for INDV?

5 equities research analysts have issued 12 month price objectives for Indivior's stock. Their forecasts range from GBX 114 to GBX 398. On average, they anticipate Indivior's stock price to reach GBX 194.40 in the next twelve months. This suggests a possible upside of 300.3% from the stock's current price. View Analyst Price Targets for Indivior.

What is the consensus analysts' recommendation for Indivior?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Indivior in the last year. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Indivior.

Has Indivior been receiving favorable news coverage?

Press coverage about INDV stock has trended negative this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Indivior earned a news impact score of -2.1 on InfoTrie's scale. They also assigned media stories about the specialty pharmaceutical company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days.

Who are some of Indivior's key competitors?

What other stocks do shareholders of Indivior own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Indivior investors own include Bigblu Broadband (BBB), Directa Plus (DCTA), Futura Medical (FUM), Lakehouse (LAKE), Umicore (UMI), Aquila Services Group (AQSG), Benchmark (BMK), Bodycote (BOY), CityFibre Infrastructure (CITY) and Deltex Medical Group (DEMG).

Who are Indivior's key executives?

Indivior's management team includes the folowing people:
  • Mr. Shaun Thaxter, CEO & Exec. Director
  • Mr. Mark Crossley, CFO & Exec. Director
  • Dr. Christian Heidbreder, Chief Scientific Officer
  • Mr. Ingo Elfering, Chief Information & Innovation Officer
  • Mr. Jason Thompson, VP of Investor Relations

How do I buy shares of Indivior?

Shares of INDV and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Indivior's stock price today?

One share of INDV stock can currently be purchased for approximately GBX 48.56.

How big of a company is Indivior?

Indivior has a market capitalization of £354.50 million and generates £988 million in revenue each year. Indivior employs 915 workers across the globe.

What is Indivior's official website?

The official website for Indivior is http://indivior.com/.

How can I contact Indivior?

Indivior's mailing address is 103-105 Bath Road, SLOUGH, SL1 3UH, United Kingdom. The specialty pharmaceutical company can be reached via phone at +44-1753-217800.


MarketBeat Community Rating for Indivior (LON INDV)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  441 (Vote Outperform)
Underperform Votes:  220 (Vote Underperform)
Total Votes:  661
MarketBeat's community ratings are surveys of what our community members think about Indivior and other stocks. Vote "Outperform" if you believe INDV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INDV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/19/2019 by MarketBeat.com Staff

Featured Article: What is a put option?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel